ICM

Carnot institute

The ICM Carnot Institute is comprised of a research center, a center for clinical investigation and an incubator for start-ups dedicated to finding solutions for diseases and disorders of the central nervous system.

Headquartered in a 22,000 sqm building equipped with the latest technological core facilities, our goal is to promote strong partnerships as a means to accelerate translational research and respond to industry actors unmet needs.

Competences

Core business

Health
Technologies for health
Key figures

Key figures

Permanent staff (full-time equivalent)
440
including PhD Students
95
Global budget
41,2 M€
Partnership
incomes with industry
11 M€
Contact

Contact

institut Carnot ICM
Hôpital Pitié-Salpétrière,
47/83 boulevard de l'hôpital
75013 Paris

Office of Research and
Technology Development
+33 (0)1 57 27 40 69

Email contact
Parent institutions

Parent institutions

  • ICM
  • CNRS
  • Inserm
  • APHP
  • UPMC

Presentation

The ICM addresses brain and spinal cord disorders by accelerating the development of new health solutions

Personalised Medicine

The ICM has structured its research strategy into key thematic and transversal axis according to the unmet needs of «translational» research in the field of Neuroscience.

Patient cohorts, biomarkers identification and the validation of new therapeutic targets allow for patients affected by Parkinson’s disease, Alzheimer’s disease, multiple sclerosis or neuro-oncological tumors to benefit from personalized diagnosis and foresight into how they will respond to treatments.

Medtech approaches

Identified biomarkers can be circulating molecules, neuroimaging signals, electroencephalographic traces, responses to cognitive tests or other «markers». Those new markers and their combination are identified at ICM by capitalizing on extensive patients cohorts and through the development of new technologies, used as measurement tools as well as a means to modulate brain activity: deep brain stimulation, therapeutic ultrasounds, transcranial magnetic stimulation, etc. are being developed at the ICM Carnot Institute thanks to 7,000 sqm of technological core facilities.

Target markets

  • Biotechnology
  • Medical technology
  • Digital health

 

Digital tools for active ageing and disease monitoring

With the view of constructing a “hospital of the future”, promoting home-based care for patients and preventing age-related comorbidities, the ICM Carnot Institute is developing, thanks to its joint academia/industry laboratories and the innovative companies of its iPEPS-ICM incubator, ultra-early diagnostic tools for diseases and digital tools for maintaining patients’ autonomy: smartphone applications, connected devices, medical devices, serious games. In order to understand and manage motivation-related disorders, a unique living lab allows for experimentation around potential solutions.

Knowledge and know-how

  • Genetics
  • Transgenesis
  • Preclinical studies
  • Clinical trials
  • Neuroimaging
  • Biostatistics
  • Biomarker research

Examples of core facilities:

  • Virtual reality
  • MEG/EEG
  • MRI
  • Cellular imaging
  • Electrophysiology
  • Preclinical functional exploration
      Deep Brain Stimulation in Parkinson’s disease: treatment consists of electrically stimulating a deep brain structure called the subthalamic nucleus, which causes a dramatic decrease in motor disorders. Electrodes are implanted in a specific region of the brain and are stimulated via a pacemaker, placed under the skin at the patient’s clavicle. (Atlas YeB).

 

29 Carnot institutes 9 Associated Carnot
Texte anglais

3BCAR

Bioenergy, Biomolecules and Biomaterials from Renewable Carbon

ARTS

Research Actions for Technology and Society

brgm

BRGM, the French geological survey

CALYM

The Consortium for the acceleration of innovation and its transfer in the lymphoma field

ESP

Energy and Propulsion Systems (ESP)

ICM

Imagine

IMAGINE - Institut des maladies génétiques

Ingénierie@Lyon

Innovative materials and processes – Intelligent machines...from designing an object to its final use.

Innovation Chimie Carnot (I2C)

Innovation Chimie Carnot (I2C)

Irstea

French National Research Institute of Science and Technology for Environment and Agriculture

ISIFoR

Sustainable engineering of georesources

Leti

Laboratoire d’Electronique et de Technologies de l’Information

LSI

Software and intelligent systems (LSI)

M.I.N.E.S

Innovative methods for companies and society

MECD

Build better for a better living

Pasteur MS

The «Pasteur Microbes & Santé» Carnot Institute

Plant2Pro

Innovations to enhance the sustainable competitiveness of crop production

Smiles

SMILES : Mathematical Sciences for Innovation, Label of Strategic Excellence

STAR

Science and Technology for Research Applications